The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Current status of opioid prescription in South Korea using narcotics information management system

  • Soo-Hyuk Yoon (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Jeongsoo Kim (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Susie Yoon (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Ho-Jin Lee (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital)
  • Received : 2023.08.08
  • Accepted : 2023.10.08
  • Published : 2024.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Recognizing the seriousness of the misuse and abuse of medical narcotics, the South Korean government introduced the world's first narcotic management system, the Narcotics Information Management System (NIMS). This study aimed to explore the recent one-year opioid prescribing patterns in South Korea using the NIMS database. Methods: This study analyzed opioid prescription records in South Korea for the year 2022, utilizing the dispensing/administration dataset provided by NIMS. Public data from the Korean Statistical Information Service were also utilized to explore prescription trends over the past four years. The examination covered 16 different opioid analgesics, assessed by the total number of units prescribed based on routes of administration, type of institutions, and patients' sex and age group. Additionally, the disposal rate for each ingredient was computed. Results: In total, 206,941 records of 87,792,968 opioid analgesic units were analyzed. Recently, the overall quantity of prescribed opioid analgesic units has remained relatively stable. The most prescribed ingredient was oral oxycodone, followed by tapentadol and sublingual fentanyl. Tertiary hospitals had the highest number of dispensed units (49.4%), followed by community pharmacies (40.2%). The highest number of prescribed units was attributed to male patients in their 60s. The disposal rates of the oral and transdermal formulations were less than 0.1%. Conclusions: Opioid prescription in South Korea features a high proportion of oral formulations, tertiary hospital administration, pharmacy dispensing, and elderly patients. Sustained education and surveillance of patients and healthcare providers is required.

Keywords

Acknowledgement

We would like to thank the Korea Institute of Drug Safety & Risk Management for providing the dataset and responding to inquiries.

References

  1. Macintyre PE, Quinlan J, Levy N, Lobo DN. Current issues in the use of opioids for the management of postoperative pain: a review. JAMA Surg 2022; 157: 158-66. https://doi.org/10.1001/jamasurg.2021.6210
  2. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet 2019; 394: 1560-79. https://doi.org/10.1016/S0140-6736(19)32229-9
  3. Walther Global Palliative Care & Supportive Oncology. Essential controlled medicines consumption data trends from 1985 to 2020 (Republic of Korea) [Internet]. Indiana University Simon Comprehensive Cancer Center; 2022. Available at: https://walthercenter.iu.edu/essential-medicines/country/republic-korea.html
  4. Supreme Prosecutor's Office. Domestic narcotic drug crime report (2022) [Internet]. Supreme Prosecutor's Office; 2023. Available at: https://www.spo.go.kr/site/spo/ex/board/List.do?cbIdx=1204&site=mapping_hyperlink
  5. The Catholic University of Korea. The survey of drug users in Korea 2021 [Internet]. National Center for Mental Health; 2021. Available at: https://mhs.ncmh.go.kr/research/4?mid=a10201000000&seq=15
  6. Kim MJ, Kim JY, Lim YH, Hong SJ, Jeong JH, Choi HR, et al. Actual situation and prescribing patterns of opioids by pain physicians in South Korea. Korean J Pain 2022; 35: 475-87. https://doi.org/10.3344/kjp.2022.35.4.475
  7. Anderson D, Zlateva I, Khatri K, Ciaburri N. Using health information technology to improve adherence to opioid prescribing guidelines in primary care. Clin J Pain 2015; 31: 573-9. https://doi.org/10.1097/AJP.0000000000000177
  8. Vuolo M, Frizzell LC, Kelly BC. Surveillance, self-governance, and mortality: the impact of prescription drug monitoring programs on U.S. overdose mortality, 2000-2016. J Health Soc Behav 2022; 63: 337-56. https://doi.org/10.1177/00221465211067209
  9. Kim SY, Cho NW, Yoo MS, Han SY, Oh JW. Narcotics information management system in South Korea: system development and innovation. BMC Health Serv Res 2023; 23: 73.
  10. Oh TK, Jeon YT, Choi JW. Trends in chronic opioid use and association with five-year survival in South Korea: a population-based cohort study. Br J Anaesth 2019; 123: 655-63. https://doi.org/10.1016/j.bja.2019.08.012
  11. Cho NR, Chang YJ, Lee D, Kim JR, Ko DS, Choi JJ. Trends in opioid prescribing practices in South Korea, 2009-2019: are we safe from an opioid epidemic? PLoS One 2021; 16: e0250972.
  12. Korean Statistical Information Service. Prescription status of medical narcotics by efficacy and constituent [Internet]. Korean Statistical Information Service; 2023. Available at: https://kosis.kr/statHtml/statHtml.do?orgId=145&tblId=DT_145013_044&vw_cd=MT_ZTITLE&list_id=F_45_004&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=MT_ZTITLE&path=%252FstatisticsList%252FstatisticsListIndex.do
  13. Kim J, Shin SJ, Yoon J, Kim HS, Lee JW, Kim YS, et al. Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort. Epidemiol Health 2022; 44: e2022029.
  14. Kim S, Kim E, Suh HS. Cost-effectiveness of an opioid abuse-prevention program using the narcotics information management system in South Korea. Value Health 2021; 24: 174-81. https://doi.org/10.1016/j.jval.2020.12.002
  15. Kim J, Shin YJ. Qualitative study on the narcotics information management system (NIMS) experience of doctors and pharmacists using narcotic analgesics. Korean J Clin Pharm 2023; 33: 22-34. https://doi.org/10.24304/kjcp.2023.33.1.22
  16. Jayawardana S, Forman R, Johnston-Webber C, Campbell A, Berterame S, de Joncheere C, et al. Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study. EClinicalMedicine 2021; 42: 101198.
  17. Slivicki RA, Earnest T, Chang YH, Pareta R, Casey E, Li JN, et al. Oral oxycodone self-administration leads to features of opioid misuse in male and female mice. Addict Biol 2023; 28: e13253.
  18. Kirsh K, Peppin J, Coleman J. Characterization of prescription opioid abuse in the United States: focus on route of administration. J Pain Palliat Care Pharmacother 2012; 26: 348-61. https://doi.org/10.3109/15360288.2012.734905
  19. Reddy A, de la Cruz M. Safe opioid use, storage, and disposal strategies in cancer pain management. Oncologist 2019; 24: 1410-5. https://doi.org/10.1634/theoncologist.2019-0242
  20. Cepeda MS, Fife D, Kihm MA, Mastrogiovanni G, Yuan Y. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse. Clin J Pain 2014; 30: 1051-6. https://doi.org/10.1097/AJP.0000000000000067
  21. Wightman R, Perrone J, Portelli I, Nelson L. Likeability and abuse liability of commonly prescribed opioids. J Med Toxicol 2012; 8: 335-40. https://doi.org/10.1007/s13181-012-0263-x
  22. Kuczynska K, Grzonkowski P, Kacprzak L, Zawilska JB. Abuse of fentanyl: an emerging problem to face. Forensic Sci Int 2018; 289: 207-14. https://doi.org/10.1016/j.forsciint.2018.05.042
  23. Lee JH. Still a threatening opioid wave: it is time for the protagonist to step up! Korean J Pain 2023; 36: 1-3. https://doi.org/10.3344/kjp.22403
  24. Butler SF, McNaughton EC, Black RA. Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment. Pain Med 2015; 16: 119-30. https://doi.org/10.1111/pme.12524
  25. Chang EJ, Choi EJ, Kim KH. Tapentadol: can it kill two birds with one stone without breaking windows? Korean J Pain 2016; 29: 153-7. https://doi.org/10.3344/kjp.2016.29.3.153
  26. Buffington DE, Lozicki A, Alfieri T, Bond TC. Understanding factors that contribute to the disposal of unused opioid medication. J Pain Res 2019; 12: 725-32. https://doi.org/10.2147/JPR.S171742
  27. Ramel CL, Habermann EB, Thiels CA, Dierkhising RA, Cunningham JL. Provision of a drug deactivation system for unused opioid disposal at surgical dismissal: opportunity to reduce community opioid supply. Mayo Clin Proc Innov Qual Outcomes 2020; 4: 357-61. https://doi.org/10.1016/j.mayocpiqo.2020.04.007
  28. Welham GC, Mount JK, Gilson AM. Type and frequency of opioid pain medications returned for disposal. Drugs Real World Outcomes 2015; 2: 129-35. https://doi.org/10.1007/s40801-015-0019-4
  29. Gregorian R, Marrett E, Sivathanu V, Torgal M, Shah S, Kwong WJ, et al. Safe opioid storage and disposal: a survey of patient beliefs and practices. J Pain Res 2020; 13: 987-95. https://doi.org/10.2147/JPR.S242825
  30. Schafer WLA, Johnson JK, Wafford QE, Plummer SG, Stulberg JJ. Primary prevention of prescription opioid diversion: a systematic review of medication disposal interventions. Am J Drug Alcohol Abuse 2021; 47: 548-58. https://doi.org/10.1080/00952990.2021.1937635
  31. Ministry of Food and Drug Safety. Article 50 of narcotics control act [Internet]. Korea Ministry of Government Legislation; 2013. Available at: https://www.law.go.kr/%EB%B2%95%EB%A0%B9/%EB%A7%88%EC%95%BD%EB%A5%98%EA%B4%80%EB%A6%AC%EC%97%90%EA%B4%80%ED%95%9C%EB%B2%95%EB%A5%A0
  32. Chisholm-Burns MA, Spivey CA, Sherwin E, Wheeler J, Hohmeier K. The opioid crisis: origins, trends, policies, and the roles of pharmacists. Am J Health Syst Pharm 2019; 76: 424-35. https://doi.org/10.1093/ajhp/zxy089
  33. Eukel H, Steig J, Frenzel O, Skoy E, Werremeyer A, Strand M. Opioid misuse and overdose: changes in pharmacist practices and outcomes. J Contin Educ Health Prof 2020; 40: 242-7. https://doi.org/10.1097/CEH.0000000000000317
  34. Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open 2016; 6: e010364.
  35. Jensen-Dahm C, Gasse C, Astrup A, Mortensen PB, Waldemar G. Frequent use of opioids in patients with dementia and nursing home residents: a study of the entire elderly population of Denmark. Alzheimers Dement 2015; 11: 691-9. https://doi.org/10.1016/j.jalz.2014.06.013
  36. Levi-Minzi MA, Surratt HL, Kurtz SP, Buttram ME. Under treatment of pain: a prescription for opioid misuse among the elderly? Pain Med 2013; 14: 1719-29. https://doi.org/10.1111/pme.12189
  37. Roberto KA, Teaster PB, Lindberg BW, Blancato R. A first (and disturbing) look at the relationship between the opioid epidemic and elder abuse: insights of human service professionals. J Appl Gerontol 2021; 40: 1231-5.
  38. Yoon D, Lee H, Baek YH, Jeong HE, Shin JY. Prevalence and its correlation with sustained opioid use in Korea: a group-based trajectory analysis. J Psychoactive Drugs 2021; 53: 224-9. https://doi.org/10.1080/02791072.2020.1856456
  39. Litman RS, Pagan OH, Cicero TJ. Abuse-deterrent opioid formulations. Anesthesiology 2018; 128: 1015-26. https://doi.org/10.1097/ALN.0000000000002031